Browsing by Author "Ramratnam, Sima"

Now showing 1 - 1 of 1
  • Thumbnail Image
    Item
    Determinants of Lung Function Across Childhood in the Severe Asthma Research Program (SARP) 3
    (Elsevier, 2023) Gaffin, Jonathan M.; Petty, Carter R.; Sorkness, Ronald L.; Denlinger, Loren C.; Phillips, Brenda R.; Ly, Ngoc P.; Gaston, Benjamin; Ross, Kristie; Fitzpatrick, Anne; Bacharier, Leonard B.; DeBoer, Mark D.; Teague, W. Gerald; Wenzel, Sally E.; Ramratnam, Sima; Israel, Elliot; Mauger, David T.; Phipatanakul, Wanda; National Heart, Lung and Blood Institute’s Severe Asthma Research Program-3 Investigators; Pediatrics, School of Medicine
    Background: Children with asthma are at risk for low lung function extending into adulthood, but understanding of clinical predictors is incomplete. Objective: We sought to determine phenotypic factors associated with FEV1 throughout childhood in the Severe Asthma Research Program 3 pediatric cohort. Methods: Lung function was measured at baseline and annually. Multivariate linear mixed-effects models were constructed to assess the effect of baseline and time-varying predictors of prebronchodilator FEV1 at each assessment for up to 6 years. All models were adjusted for age, predicted FEV1 by Global Lung Function Initiative reference equations, race, sex, and height. Secondary outcomes included postbronchodilator FEV1 and prebronchodilator FEV1/forced vital capacity. Results: A total of 862 spirometry assessments were performed for 188 participants. Factors associated with FEV1 include baseline Feno (B, -49 mL/log2 PPB; 95% CI, -92 to -6), response to a characterizing dose of triamcinolone acetonide (B, -8.4 mL/1% change FEV1 posttriamcinolone; 95% CI, -12.3 to -4.5), and maximal bronchodilator reversibility (B, -27 mL/1% change postbronchodilator FEV1; 95% CI, -37 to -16). Annually assessed time-varying factors of age, obesity, and exacerbation frequency predicted FEV1 over time. Notably, there was a significant age and sex interaction. Among girls, there was no exacerbation effect. For boys, however, moderate (1-2) exacerbation frequency in the previous 12 months was associated with -20 mL (95% CI, -39 to -2) FEV1 at each successive year. High exacerbation frequency (≥3) 12 to 24 months before assessment was associated with -34 mL (95% CI, -61 to -7) FEV1 at each successive year. Conclusions: In children with severe and nonsevere asthma, several clinically relevant factors predict FEV1 over time. Boys with recurrent exacerbations are at high risk of lower FEV1 through childhood.